Valuation: Medpace Holdings, Inc.

Market Cap 17.31B 14.83B 13.87B 12.68B 23.94B 1,657B 24.19B 164B 63.84B 832B 64.98B 63.57B 2,753B P/E 2026 *
35.3x
P/E 2027 * 32.4x
Enterprise Value 16.5B 14.14B 13.23B 12.1B 22.83B 1,580B 23.07B 157B 60.88B 794B 61.97B 60.62B 2,625B EV / Sales 2026 *
5.79x
EV / Sales 2027 * 5.3x
Free-Float
80.09%
Yield 2026 *
-
Yield 2027 * -
1 day-0.95%
1 week+4.28%
Current month+6.66%
1 month+4.44%
3 months+43.45%
6 months+40.51%
Current year+9.59%
1 week 596.22
Extreme 596.22
629.69
1 month 563.45
Extreme 563.45
629.69
Current year 373
Extreme 373
677.9
1 year 373
Extreme 373
677.9
3 years 227.21
Extreme 227.21
677.9
5 years 126.94
Extreme 126.945
677.9
10 years 21.76
Extreme 21.76
677.9
Manager TitleAgeSince
Chief Executive Officer 69 01/07/1992
Director of Finance/CFO 51 01/08/2021
Chief Tech/Sci/R&D Officer 65 01/09/2017
Director TitleAgeSince
Chairman 69 01/07/1992
Director/Board Member 55 01/07/2016
Director/Board Member 72 01/07/2016
Date Insider Type Main position Quantity % Market Cap.
8/20/26 A Sell

Chief Executive Officer

-27,174 0.0974%
8/19/26 A Sell

Director

-5,000 0.0179%
8/19/26 A Fiscal year

Director

22,449 0.0804%
Change 5-day change 1-year change 3-year change Capi.($)
-0.95%+4.28%+31.86%+136.91% 17.31B
+1.26%+5.48%+4.19%+26.09% 51.21B
+1.57%-1.18%+498.40%+544.09% 45.35B
+0.04%+8.40%+38.39%+18.81% 42.84B
+1.35%+1.82%+21.79%+89.45% 42.29B
-2.27%-5.67%+14.55%+50.34% 32.15B
+0.60%+1.97% - - 16.55B
+1.17%+6.46%+11.12%+32.76% 14.84B
-0.62%+6.29%+80.82%+48.08% 14.25B
-2.10%+1.87%-0.92%-33.61% 13.38B
Average +0.01%+2.99%+77.80%+101.44% 29.02B
Weighted average by Cap. +0.33%+2.87%+101.26%+129.04%

Financials

2026 *2027 *
Net sales 2.85B 2.44B 2.29B 2.09B 3.94B 273B 3.99B 27.05B 10.52B 137B 10.71B 10.48B 454B 3.03B 2.59B 2.43B 2.22B 4.19B 290B 4.23B 28.72B 11.17B 146B 11.37B 11.12B 482B
Net income 503M 431M 403M 368M 695M 48.12B 703M 4.77B 1.85B 24.16B 1.89B 1.85B 79.95B 547M 468M 438M 401M 756M 52.34B 764M 5.19B 2.02B 26.28B 2.05B 2.01B 86.95B
Net Debt -802M -688M -643M -588M -1.11B -76.82B -1.12B -7.61B -2.96B -38.57B -3.01B -2.95B -128B -1.25B -1.07B -1B -918M -1.73B -120B -1.75B -11.88B -4.62B -60.21B -4.7B -4.6B -199B
Logo Medpace Holdings, Inc.
Medpace Holdings, Inc. is a scientifically driven, global, full-service clinical contract research organization (CRO) providing phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. The Company partners with pharmaceutical, biotechnology, and medical device companies in the development and execution of clinical trials. The Company's drug development services focus on full-service Phase I-IV clinical development services and include development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support. The Company also provides bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. The Company's operations are principally based in North America, Europe, and Asia.
Employees
6,500
Date Price Change Volume
25/08/26 $615.54 -0.72% 28,335
24/08/26 $620.03 -0.12% 186,216
21/08/26 $620.75 +1.32% 225,882
20/08/26 $612.64 +0.72% 254,525
19/08/26 $608.27 +3.04% 169,054
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
13
Last Close Price
620.03USD
Average target price
581.83USD
Spread / Average Target
-6.16%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. MEDP Stock